INTERNATIONAL PATENT: RONGCAN (SHANGHAI) BIOTECH CO., LTD, 荣灿生物医药技术（上海）有限公司 FILES APPLICATION FOR "LIPID NANOPARTICLES FOR TARGETED HIGH-EFFICIENCY DELIVERY OF NUCLEIC ACID TO LUNG, INHALED FORMULATION AND USE"

GENEVA, Oct. 26 -- RONGCAN (SHANGHAI) BIOTECH CO., LTD (No. 46, Lane 100, Banxia RoadPudong New Area, Shanghai 201318), 荣灿生物医药技术（上海）有限公司 (中国上海市浦东新区半夏路100弄46号) filed a patent application (PCT/CN2025/087889) for "LIPID NANOPARTICLES FOR TARGETED HIGH-EFFICIENCY DELIVERY OF NUCLEIC ACID TO LUNG, INHALED FORMULATION, AND USE" on Apr 08, 2025. With publication no. WO/2025/218536, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classif...